# Award #75N93026D00012

Multi-Year IDV Contract for Antimicrobial Activity Research with University of Alabama

**Buyer:** National Institutes of Health

**Award Amount:** $2,500.00
**Ceiling:** $2,500.00

**Awarded:** September 30, 2026
**Period of Performance:** Sep 30, 2026 - Sep 29, 2036

**Identifier:** 75N93026D00012
**NAICS:** 541714

This award is a multi-year indefinite delivery vehicle (IDV) contract granted to the University of Alabama at Birmingham, a premier academic and research institution. The contract focuses on conducting in vitro assessments of antimicrobial activity, a critical area of study for health and pharmaceutical sectors. The agency gains specialized scientific evaluations that support public health initiatives and promote advancements in antimicrobial research. The scope encompasses extensive laboratory testing and analysis of various antimicrobial agents to evaluate their efficacy and safety. This competitively awarded, decade-long agreement ensures ongoing collaboration and a steady supply of valuable scientific services. No subcontractors or prior contracts were noted. This partnership significantly contributes to enhancing antimicrobial research capabilities.

### Description

IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)

[View original record](https://www.usaspending.gov/award/CONT_IDV_75N93026D00012_7529)